Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation

NCT00073879 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

BIOLOGICAL: alemtuzumab
BIOLOGICAL: graft-versus-tumor induction therapy
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Baylor College of Medicine